Concepedia

Michael Shephard

MS

Statistics

Publications

10

Citations

734

H-Index

10

Active since

1963

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Alaska Anchorage

US Forest Service

Michael Shephard is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, metastatic melanoma treatment, and immunotherapy.

Publications per year

1963–2020

10

Publications

10

Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study

Meredith Pelster, Stephen K. Gruschkus, Roland L. Bassett et al. · Journal of Clinical Oncology · 2020 · 304 citations · Full text

, , +17

The Blood Volume of the Newborn Infant and Placental Transfusion

Robert Usher, Michael Shephard, John Lind · Acta Paediatrica · 1963 · 272 citations

, , +12

Safety and preliminary activity data from a single center phase II study of triplet combination of nivolumab (N) with dabrafenib (D) and trametinib (T) [trident] in patients (Pts) with BRAF-mutated metastatic melanoma (MM).

Hussein Tawbi, Rodabe N. Amaria, Isabella Claudia Glitza et al. · Journal of Clinical Oncology · 2018 · 25 citations

, , +17

Phase II study of ipilimumab and nivolumab (ipi/nivo) in metastatic uveal melanoma (UM).

Meredith Pelster, Stephen K. Gruschkus, Roland L. Bassett et al. · Journal of Clinical Oncology · 2019 · 25 citations

, , +17

Alaska Melilotus Invasions: Distribution, Origin, and Susceptibility of Plant Communities

Jeffery S. Conn, Katherine L. Beattie, Michael Shephard et al. · Arctic Antarctic and Alpine Research · 2008 · 22 citations · Full text

, , +16

1–5 of 10